Search Ontology:
ChEBI
(2R,3R,4R,5S)-5-[(1R)-2-[(2R,3R,4R,5R)-5-[(1R)-1-[(2R,3R,4R,5S)-5-[(1R)-1,2-Dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-hydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-1-hydroxyethyl]oxolane-2,3,4-triol
- Term ID
- CHEBI:153220
- Synonyms
-
- beta-D-galacto-hexofuranosyl-(1->5)-beta-D-galacto-hexofuranosyl-(1->6)-beta-D-galacto-hexofuranose
- Galf(b1-5)Galf(b1-6)b-Galf
- WURCS=2.0/1,3,2/[a2112h-1b_1-4]/1-1-1/a6-b1_b5-c1
- Definition
- References
-
- GlyGen:G69030ZC
- GlyTouCan:G69030ZC
- Ontology
- ChEBI ( EBI )
- is a type of
-
Show first 5 Terms
Phenotype
Phenotype resulting from (2R,3R,4R,5S)-5-[(1R)-2-[(2R,3R,4R,5R)-5-[(1R)-1-[(2R,3R,4R,5S)-5-[(1R)-1,2-Dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-hydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-1-hydroxyethyl]oxolane-2,3,4-triol
Phenotype where environments contain (2R,3R,4R,5S)-5-[(1R)-2-[(2R,3R,4R,5R)-5-[(1R)-1-[(2R,3R,4R,5S)-5-[(1R)-1,2-Dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-hydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-1-hydroxyethyl]oxolane-2,3,4-triol
Phenotype modified by environments containing (2R,3R,4R,5S)-5-[(1R)-2-[(2R,3R,4R,5R)-5-[(1R)-1-[(2R,3R,4R,5S)-5-[(1R)-1,2-Dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-hydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-1-hydroxyethyl]oxolane-2,3,4-triol
Human Disease Model